19-42522070-G-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 0P and 0B.
The NM_001712.5(CEACAM1):c.557C>A(p.Pro186Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00135 in 1,614,162 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/23 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001712.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CEACAM1 | NM_001712.5 | c.557C>A | p.Pro186Gln | missense_variant | 3/9 | ENST00000161559.11 | NP_001703.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CEACAM1 | ENST00000161559.11 | c.557C>A | p.Pro186Gln | missense_variant | 3/9 | 1 | NM_001712.5 | ENSP00000161559.6 |
Frequencies
GnomAD3 genomes AF: 0.000828 AC: 126AN: 152160Hom.: 1 Cov.: 32
GnomAD3 exomes AF: 0.000744 AC: 187AN: 251492Hom.: 0 AF XY: 0.000780 AC XY: 106AN XY: 135920
GnomAD4 exome AF: 0.00141 AC: 2059AN: 1461884Hom.: 1 Cov.: 32 AF XY: 0.00131 AC XY: 953AN XY: 727244
GnomAD4 genome AF: 0.000821 AC: 125AN: 152278Hom.: 1 Cov.: 32 AF XY: 0.000846 AC XY: 63AN XY: 74462
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 29, 2024 | The c.557C>A (p.P186Q) alteration is located in exon 3 (coding exon 3) of the CEACAM1 gene. This alteration results from a C to A substitution at nucleotide position 557, causing the proline (P) at amino acid position 186 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at